Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China

Clinical trial NCT07710586 · COMPLETED

Trial details

NCT number: NCT07710586
Sponsor: Ab&B Bio-tech Co., Ltd.JS
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza Vaccine

Start date: 2024-11-15
Primary completion: 2025-05-29
Enrollment: 3105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.